Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 230,056 | 153,180 | 115,450 | 89,594 | 81,487 |
| Cost of Goods | 76,003 | 36,731 | 16,269 | 12,402 | 3,030 |
| Gross Profit | 154,053 | 116,449 | 99,181 | 77,192 | 78,457 |
| Operating Expenses | 100,180 | 72,721 | 72,219 | 68,398 | 70,170 |
| Operating Income | 53,876 | 44,459 | 27,231 | 9,196 | 8,317 |
| Interest Expense | 23,761 | 6,854 | 1,520 | 1,894 | 2,346 |
| Other Income | -15,740 | 6,070 | 1,422 | 3,641 | 2,006 |
| Pre-tax Income | 14,375 | 43,675 | 27,133 | 10,943 | 7,977 |
| Income Tax | -4,112 | 10,304 | 14,005 | 3,928 | 2,916 |
| Net Income Continuous | 18,487 | 33,371 | 13,128 | 7,015 | 5,061 |
| Net Income | $18,487 | $33,371 | $13,128 | $7,015 | $5,061 |
| EPS Basic Total Ops | 0.43 | 0.76 | 0.30 | 0.17 | 0.12 |
| EPS Basic Continuous Ops | 0.43 | 0.76 | 0.30 | 0.17 | 0.12 |
| EPS Diluted Total Ops | 0.42 | 0.73 | 0.29 | 0.16 | 0.12 |
| EPS Diluted Continuous Ops | 0.42 | 0.73 | 0.30 | 0.16 | 0.12 |
| EPS Diluted Before Non-Recurring Items | 1.51 | 0.99 | 0.40 | 0.22 | 0.12 |
| EBITDA(a) | $99,559 | $55,160 | $28,403 | $10,794 | $9,872 |